Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOX + Cetuximab in Metastatic Colorectal Cancer
NCT00660582Phase 2Completed
- Sponsor
- Pfeiffer Pharmaceuticals
- Start
- Apr 2008
- Primary completion
- May 2011
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of KL-140 in metastatic colorectal cancer (mCRC), sponsored by Pfeiffer Pharmaceuticals. Started Apr 2008; status: completed.
02
Drugs
KL-140
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00660582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660582.